FavorHealth Overview
- Founded
-
2016

- Status
-
Private
- Employees
-
3

- Latest Deal Type
-
2ndary - Private
FavorHealth General Information
Description
Developer of a healthcare tool designed for real-time instructions in surgery. The company's platform automates instructions, education, communications, collects pain scores and wound site images, comply with doctor's instructions, avoid delays in care, complications, re-admissions and send interactive reminders, enabling physicians to improve communications, compliance, and outcomes for their patients and provide surgical teams with a digital platform to customize pre and post-op instructions.
Contact Information
Website
www.favorhealth.org
Formerly Known As
Track My Recovery
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Information Services (B2C)
Primary Office
- 826 Norsota Way
- Sarasota, FL 34242
- United States
FavorHealth Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Secondary Transaction - Private | 02-Mar-2022 | Completed | Startup | |||
1. Early Stage VC | Completed | Startup |
FavorHealth Patents
FavorHealth Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20050260422-A1 | Prevents growth of molds, mildew, algae, bacteria and other microbes on wood | Active | 08-Nov-2002 | 000000000 | |
US-7205052-B2 | Prevents growth of molds, mildew, algae, bacteria and other microbes on wood | Inactive | 08-Nov-2002 | 000000000 | |
AU-2003287592-A1 | Microbiological abatement coating system | Inactive | 08-Nov-2002 | 000000000 | |
AU-2003287592-A8 | Microbiological abatement coating system | Inactive | 08-Nov-2002 | 000000000 | |
US-6844081-B2 | Water, weather and microorganism resistant wood; treated with penetrating solution having boric acid crosslinking agent, catalyst, initiator and polymer; topcoated with film forming polymer containing encapsulated biocide; nonleaching | Active | 08-Nov-2002 | B27K3/156 |
FavorHealth Executive Team (6)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Hakim Morsli MD | Co-Founder | ||
Jean-Marc Voyadzis MD | Co-Founder | ||
Sambou Makalou | Co-Founder | ||
Thomas Gardner | President | ||
Kenda West | Advisor |